S&CO Inc. Acquires New Holdings in Intuitive Surgical, Inc. $ISRG

S&CO Inc. bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 5,121 shares of the medical equipment provider’s stock, valued at approximately $2,036,000.

Several other hedge funds also recently bought and sold shares of ISRG. Laurel Wealth Advisors LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at about $31,000. Turning Point Benefit Group Inc. raised its position in shares of Intuitive Surgical by 833.3% during the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 50 shares during the period. Motiv8 Investments LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth about $34,000. Oakworth Capital Inc. raised its position in shares of Intuitive Surgical by 281.2% during the fourth quarter. Oakworth Capital Inc. now owns 61 shares of the medical equipment provider’s stock worth $35,000 after purchasing an additional 45 shares during the period. Finally, Main Street Group LTD bought a new position in shares of Intuitive Surgical during the 1st quarter valued at about $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the sale, the senior vice president directly owned 6,463 shares in the company, valued at $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 72 shares of the business’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $393.10, for a total transaction of $28,303.20. Following the completion of the sale, the director directly owned 179 shares in the company, valued at approximately $70,364.90. This represents a 28.69% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 17,106 shares of company stock valued at $6,949,518 over the last ninety days. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $394.51 on Friday. The stock has a 50-day simple moving average of $391.45 and a 200 day simple moving average of $441.28. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The company has a market cap of $139.37 billion, a PE ratio of 45.19, a PEG ratio of 2.85 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The firm had revenue of $2.89 billion for the quarter, compared to analysts’ expectations of $2.83 billion. During the same quarter in the previous year, the business posted $1.81 EPS. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. On average, research analysts predict that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. BTIG Research decreased their price objective on Intuitive Surgical from $512.00 to $469.00 and set a “buy” rating for the company in a research report on Friday, July 17th. Evercore set a $430.00 target price on shares of Intuitive Surgical in a report on Monday, July 6th. Deutsche Bank Aktiengesellschaft cut their price target on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a research note on Tuesday, June 2nd. Leerink Partners lowered their price objective on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a research report on Friday, July 17th. Finally, Robert W. Baird dropped their price objective on shares of Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, July 17th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $508.68.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.